The CREST-E study of creatine for Huntington disease: A randomized controlled trial

OBJECTIVE: To investigate whether creatine administration could slow progressive functional decline in adults with early symptoms of Huntington disease. METHODS: We conducted a multicenter, randomized, double-blind, placebo-controlled study of up to 40 g daily of creatine monohydrate in participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Hersch, Steven M., Schifitto, Giovanni, Oakes, David, Bredlau, Amy-Lee, Meyers, Catherine M., Nahin, Richard, Rosas, Herminia Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562960/
https://www.ncbi.nlm.nih.gov/pubmed/28701493
http://dx.doi.org/10.1212/WNL.0000000000004209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562960/
https://www.ncbi.nlm.nih.gov/pubmed/28701493
http://dx.doi.org/10.1212/WNL.0000000000004209

Ejemplares similares